The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post...
The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
With up to 500,000 infections annually, Lassa virus (LASV), the cause of Lassa fever, is one of the most prevalent etiological agents of viral hemorrhagic fever (VHF) in humans. LASV is endemic in several West African countries with sporadic cases and prolonged outbreaks observed most commonly in Sierra Leone, Liberia, Guinea and Nigeria. Additiona...
Alternative Titles
Full title
The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4600983
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4600983
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/srep14775
